Piloting Pathways With Lung Cancer Patients
The purpose of this research is to determine the feasibility of a new supportive intervention, called Pathways, for patients with advanced stage and metastatic lung cancer.
Checked against the public recordLast updated Oct 5, 2023 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Laurie McLouth
- Interventions being studied
- Behavioral: Pathways
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * new or recurrent stage IIIB, stage IIIC or stage IV non-small cell lung cancer (NSCLC) or extensive stage SCLC * 18 years of age or older * ECOG PS 0-2/Karnofsky 60-100 * 3 to 12 weeks into active cancer treatment Exclusion Criteria: * unstable brain metastases * cognitive or psychiatric condition for which participating would be inappropriate * unable to speak and read English
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of KentuckyLexington, Kentucky
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 5, 2023. Always confirm current availability with the study team.